# K132741: V.a.C. Via Negative Pressure Wound Therapy System

- Pathway: 510(k) (Special)
- Applicant: Kci USA, Inc.
- Decided: Nov 15, 2013 after 73 days
- Product code: OMP (Negative Pressure Wound Therapy Powered Suction Pump)
- Device class: 2
- Regulation: 21 CFR 878.4780
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K945062 (1995). 9 ancestors in all.
4 later devices descend from it; 4 cite it directly.
0 of 14 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K093526: V.a.C. Via Therapy System, V.a.C. Via Negative Pressure Therapy Unit, V.a.C. Via Dressing (Containing V.a.C. Granufoam D, Kci USA, Inc. (Kinetic Concepts, Inc.) (2010) Summary page 1.
- K120033: Activac Therapy Unit and Infovac Therapy Unit, Vac Ats Therapy Unit and Vac Freedom Therapy Unit, Vac Via Therapy Unit, Kci USA, Inc. (2012) Summary page 1.

## Most influential descendants
- K241515: NEXA™ NPWT System (2024), 0 descendants of its own
- K173447: V.A.C.VIA 7 Day Therapy System Kit, V.A.C.VIA Therapy Starter Kit, V.A.C.VIA Negative Pressure Wound Therapy Unit (2018), 0 descendants of its own
- K162610: NEXA Negative Pressure Wound Therapy System (2017), 0 descendants of its own
- K161432: MyNeWT Negative Pressure Wound Therapy System (2017), 0 descendants of its own

## Indications for use
The V.A.C. 0 Vian Therapy System is an integrated wound management system for use in acute, extended and home care settings. When used on open wounds, illis intended to create an environtment that promotes wvound healing by secondary or tertiary (delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting granulation tissue formation and perfus3ion, and by removing exudates and infectious material. Open wound types include: chronic, acute, traumatic, subacute and dehisced wounds, partial-tickness burns, ulcers (such as diabetic, pressure, or venious insufficiency), flaps and gmafts. When used on closed surgical incisions, itlIs intended to manage the environment of surgical incisions that continue to drain following sutured Or stapled closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy

Source page: https://510kreport.com/device/K132741
Methodology: https://510kreport.com/methodology